Studies from Tohoku University Hospital Provide New Data on Colon Cancer (Phase Ii Study of Biweekly Cetuximab Plus Mfolfox6 or Mfolfiri As Second-line Treatment for Metastatic Colorectal Cancer and Exploratory Analysis of Associations Between ...)

Press/Media

Period2023 Apr 28

Media coverage

1

Media coverage